Pathology of non-alcoholic fatty liver disease

被引:36
|
作者
Cataldo, Ivana [1 ]
Sarcognato, Samantha [1 ]
Sacchi, Diana [1 ]
Cacciatore, Matilde [1 ]
Baciorri, Francesca [1 ]
Mangia, Alessandra [2 ]
Cazzagon, Nora [3 ]
Guido, Maria [1 ,4 ]
机构
[1] Azienda ULSS 2 Marca Trevigiana, Dept Pathol, Piazzale Osped 1, Treviso, Italy
[2] Fdn IRCCS Casa Sollievo della Sofferenza, Dept Med Sci, Liver Unit, San Giovanni Rotondo, Italy
[3] Univ Padua, Dept Surg Oncol & Gastroenterol, Padua, Italy
[4] Univ Padua, Dept Med DIMED, Padua, Italy
关键词
fatty liver; steatohepatitis; non-alcoholic; metabolic syndrome; SCORING SYSTEM; STEATOHEPATITIS; NAFLD; DIAGNOSIS; FIBROSIS; PROGRESSION; DEFINITION; PREVALENCE; ALGORITHM; BIOPSY;
D O I
10.32074/1591-951X-242
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Non-alcoholic fatty liver disease (NAFLD) encompasses a spectrum of different conditions which are characterized by hepatic steatosis in the absence of secondary causes. It is currently the most common chronic liver disease worldwide, and its estimated prevalence is about 1.5-6.5%. The only histological finding of steatosis ("simple" steatosis) represents the uncomplicated form of NAFLD, while non-alcoholic steatohepatitis (NASH) is its inflammatory subtype associated with disease progression to cirrhosis and hepatocellular carcinoma (HCC), and represents the major indication for liver transplantation. NASH is still a diagnostic and therapeutic challenge for clinicians and liver biopsy is currently the only accepted method to reliably distinguish NASH from "simple" steatosis. From the histological perspectives, NAFLD and NASH continue to be an area of active interest for pathologists, with a specific focus on better methods of evaluation, morphologic clues to pathogenesis, and predictors of fibrosis progression. This review focuses on histopathology of NAFLD in adults, with the aim to provide a practical diagnostic approach useful in the clinical routine.
引用
收藏
页码:194 / 202
页数:9
相关论文
共 50 条
  • [1] Pathology of non-alcoholic fatty liver disease
    Bedossa, Pierre
    LIVER INTERNATIONAL, 2017, 37 : 85 - 89
  • [2] Non-alcoholic fatty liver disease
    Maurice, James
    Manousou, Pinelopi
    CLINICAL MEDICINE, 2018, 18 (03) : 245 - 250
  • [3] Non-alcoholic fatty Liver disease
    Calderaro, Julien
    Zafrani, Elie Serge
    ANNALES DE PATHOLOGIE, 2010, 30 (06) : 413 - 420
  • [4] Non-alcoholic fatty liver disease: A review with clinical and pathological correlation
    Chen, Yen-Ying
    Yeh, Matthew M.
    JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, 2021, 120 (01) : 68 - 77
  • [5] Non-alcoholic fatty liver disease: A public health challenge
    Brissot, P.
    Buffet, C.
    BULLETIN DE L ACADEMIE NATIONALE DE MEDECINE, 2023, 207 (05): : 521 - 533
  • [6] A Comprehensive Review on Non-Alcoholic Fatty Liver Disease
    Sahu, Prerna
    Chhabra, Pratyaksh
    Mehendale, Ashok M.
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (12)
  • [7] Role of Leptin in Non-Alcoholic Fatty Liver Disease
    Jimenez-Cortegana, Carlos
    Garcia-Galey, Alba
    Tami, Malika
    del Pino, Pilar
    Carmona, Isabel
    Lopez, Soledad
    Alba, Gonzalo
    Sanchez-Margalet, Victor
    BIOMEDICINES, 2021, 9 (07)
  • [8] Clinical presentation of alcoholic liver disease and non-alcoholic fatty liver disease: spectrum and diagnosis
    Sharma, Praveen
    Arora, Anil
    TRANSLATIONAL GASTROENTEROLOGY AND HEPATOLOGY, 2020, 5
  • [9] Repeated liver stiffness measurement compared with paired liver biopsy in patients with non-alcoholic fatty liver disease
    Kamarajah, Sivesh K.
    Chan, Wah-Kheong
    Mustapha, Nik Raihan Nik
    Mahadeva, Sanjiv
    HEPATOLOGY INTERNATIONAL, 2018, 12 (01) : 44 - 55
  • [10] Non-alcoholic fatty liver disease (NAFLD)
    Rau, Monika
    Weiss, Johannes
    Geier, Andreas
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2015, 140 (14) : 1051 - +